Skip to main content
TipRanks
Go Ultimate75% OFF

Quantum Cyber (4TO) AI Stock Analysis

8 Followers
DE:4TO

Quantum Cyber

(Frankfurt:4TO)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Improving Gross MarginGross margin's rise from about 25% to 73% indicates materially better unit economics and gives each sale more contribution toward overhead. If retained, this improvement can support commercialization and eventual operating leverage, although losses remain substantial.
Negative Factors
Persistent UnprofitabilityLarge operating and net losses show that improved gross margins have not yet translated into a sustainable earnings model. The 2025 revenue decline adds execution risk because fixed costs and development spending must be supported by an inconsistent and shrinking top line.

Quantum Cyber (4TO) vs. iShares MSCI Germany ETF (EWG)

-5%0%5%10%15%20%DE:4TO0.00%EWG+9.30%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 14.19M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-0.4
Beta (1Y)
-0.42
Revenue Growth
―
EPS Growth
―
Country
Germany
Employees
13
Sector
Healthcare
Sector Strength
51
Industry
Medical - Diagnostics & Research

Quantum Cyber Business Overview & Revenue Model

Company Description

Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national securi...

Quantum Cyber Risk Analysis

Quantum Cyber disclosed 40 risk factors in its most recent earnings report. Quantum Cyber reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

2 New Risks
1.Nasdaq maintains certain standards which Nasdaq requires listed companies meet for their respective securities to continue to be listed and traded on its exchange, and if we are unable to continue to meet such continued listing requirements, Nasdaq may choose to delist our ordinary shares from its exchange, which may adversely affect the liquidity and trading price of our ordinary shares.Q4, 2023
2.We are subject to cybersecurity risks to operational systems, security systems, infrastructure and personal data processed by us or third-party vendors or suppliers and any material failure, weakness, interruption, cyber event, incident or breach of security could prevent us from effectively operating our business or subject us to liability for mishandling sensitive data.Q4, 2023

Quantum Cyber Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:4TO against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
NDRANDRA42Neutral$5.88M-0.62-224.80%――60.87%
INBSINBS41Neutral$5.17M-0.23-146.09%―36.55%60.09%
ISPCISPC40Underperform$3.45M-0.02-356.00%―-92.11%86.78%

* Healthcare Sector Average

Performance Comparison

0%100%DE:4TONDRAINBSISPCBGLCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:4TO and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:4TOQuantum Cyber N.V.8.000.000.00%
NDRAEndra Life Sciences3.92-1.72-30.50%
INBSIntelligent Bio Solutions Inc.1.56-4.86-75.70%
ISPCIspecimen Inc0.60-16.24-96.46%
BGLCBionexus Gene Lab Corporation0.77-3.58-82.39%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.